In preneoplastic lesions, CD44v3+ cases progressively increased to reach 55.1% in intestinal metaplasia and 60.6% in GC compared to CD44 which was detected in more than 96% of cases as from the stage of intestinal metaplasia. The gene discussed is CD44; the disease is gastric cancer.